Skip to main contentSkip to navigation
Sirius Investors
Gamida Cell Ltd.

Gamida Cell Ltd.

GMDA
NASDAQHealthcare

Gamida Cell Ltd. (GMDA) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Gamida Cell Ltd.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2023
P/E Ratio
-0.98
Burn Risk
P/B Ratio
-20.79
Equity Deficit
Earnings Yield
-102.74%
Yield Gap

Profitability Health

2023
Return on Equity
2136.18%
Strong
WeakModerateStrong
Operating Margin
-4094.06%
Weak
WeakModerateStrong
Net Profit Margin
-3531.17%
Weak
WeakModerateStrong

Growth Indicators

2023
Revenue Growth
-
No data
Net Income Growth
59.19%
Strong
WeakModerateStrong
EPS Growth
82.64%
Strong
WeakModerateStrong

Efficiency & Liquidity

2023
Current Ratio
2.16
Strong
WeakModerateStrong
Quick Ratio
2.09
Strong
WeakModerateStrong
Asset Turnover
0.02x
Weak
WeakModerateStrong
Inventory Turnover
1.82x
Weak
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2023
Free Cash Flow Yield
-130.80%
Weak
WeakModerateStrong
EV / Free Cash Flow
-1.22x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.68x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.863
Moderate
WeakModerateStrong
Return on Invested Capital
-86.17%
Weak
WeakModerateStrong
Cash Conversion Cycle
332.13 days
Weak
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for GMDA.

View Financial Statements